Essex Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Essex Investment Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-220,160	Closed	-$1.08M	–	331
2024 Q1	$1.08M	Buy	220,160 +97,741	+80%	+$481K	0.21%	142
2023 Q4	$1.08M	Buy	122,419 +38,671	+46%	+$340K	0.21%	152
2023 Q3	$961K	Sell	83,748 -25,112	-23%	-$288K	0.16%	207
2023 Q2	$2.76M	Buy	108,860 +247	+0.2%	+$6.25K	0.38%	90
2023 Q1	$3.5M	Buy	108,613 +40,680	+60%	+$1.31M	0.51%	57
2022 Q4	$1.25M	Sell	67,933 -689	-1%	-$12.7K	0.2%	161
2022 Q3	$1.85M	Buy	68,622 +5,034	+8%	+$136K	0.3%	103
2022 Q2	$879K	Sell	63,588 -921	-1%	-$12.7K	0.14%	207
2022 Q1	$1.26M	Sell	64,509 -64,875	-50%	-$1.27M	0.16%	197
2021 Q4	$2.11M	Sell	129,384 -1,941	-1%	-$31.7K	0.24%	131
2021 Q3	$3.66M	Hold	131,325	–	–	0.45%	61
2021 Q2	$3.89M	Sell	131,325 -7,664	-6%	-$227K	0.45%	69
2021 Q1	$3.89M	Buy	138,989 +62,318	+81%	+$1.74M	0.47%	58
2020 Q4	$2.17M	Sell	76,671 -23,329	-23%	-$661K	0.27%	120
2020 Q3	$2.51M	Buy	100,000 +32,898	+49%	+$827K	0.36%	75
2020 Q2	$1.64M	Sell	67,102 -32,898	-33%	-$804K	0.27%	112
2020 Q1	$1.48M	Buy	+100,000	New	+$1.48M	0.3%	103
2018 Q4	–	Sell	-87,355	Closed	-$2.17M	–	539
2018 Q3	$2.17M	Hold	87,355	–	–	0.26%	121
2018 Q2	$2.4M	Sell	87,355 -24,005	-22%	-$659K	0.3%	102
2018 Q1	$3.43M	Sell	111,360 -7,592	-6%	-$234K	0.45%	59
2017 Q4	$4.25M	Buy	118,952 +14,024	+13%	+$501K	0.56%	39
2017 Q3	$2.89M	Sell	104,928 -20,004	-16%	-$551K	0.39%	64
2017 Q2	$3.3M	Buy	124,932 +26,248	+27%	+$693K	0.47%	50
2017 Q1	$2.05M	Buy	98,684 +7,456	+8%	+$155K	0.32%	85
2016 Q4	$1.89M	Buy	91,228 +5,228	+6%	+$108K	0.31%	87
2016 Q3	$1.39M	Buy	86,000 +4,299	+5%	+$69.7K	0.22%	109
2016 Q2	$1.11M	Hold	81,701	–	–	0.18%	128
2016 Q1	$1.43M	Buy	81,701 +10,000	+14%	+$175K	0.24%	90
2015 Q4	$2.45M	Hold	71,701	–	–	0.38%	61
2015 Q3	$2.13M	Hold	71,701	–	–	0.35%	64
2015 Q2	$2.29M	Buy	+71,701	New	+$2.29M	0.35%	78